iMetabolic Biopharma Corporation — Form C-AR (Regulation Crowdfunding)

iMetabolic Biopharma Corporation of Phoenix, AZ filed a Form C-AR (Regulation Crowdfunding) with the SEC on 2026-05-06.

Offering

• Filed: 2026-05-06
• Form: C-AR
• Accession: 0001957114-26-000001

Issuer

• CIK: 0001957114
• Website: https://imbiopharma.com/
• Legal status: Corporation
• Organized in: NV
• Incorporated: 2017-11-17
• Address: 275 N Gateway Dr, Suite 104, Phoenix, AZ, 85034
• Employees: 4

Financials (as filed)

• Total assets (most recent): $28K
• Cash (most recent): $26K
• Revenue (most recent): $137K
• Revenue (prior): $130K
• Net income (most recent): $-100K
• Net income (prior): $-120K
• Short-term debt: $65K
• Long-term debt: $558K

People (4)

Reg CF filing history (8)

More

• CIK 1957114 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search